OpenVSafe by OpenVAERS
Search V-safe

BTE-98096-64082

3 vaccinations 10 coded responses 27 check-ins 10 free-text entries 7 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
200 / DC
Registered
2022-04-08
Relationship
Self
Race
Native Hawaiian or other Pacific Islander
Ethnicity
Hispanic or Latino

Timeline

  1. 2022-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2022-04-08
    Registered in v-safe
  3. 2022-04-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2022-04-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2022-04-19
    Dose 2 — Pfizer-BioNTech
  6. 2022-04-19
    Survey response — day 0, dose 2
    MedDRA: Fatigue — Feeling: Fair
    Free text: Tiredness
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-04-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: I have fibromyalgia so I believe the shot is just heightened the pain because I do NOT have flu symptoms
    MedDRA releases: 2024-11 · check-in free text available
  8. 2022-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Joint pains · Be unable to do your normal daily activities
    Adult check-in
  9. 2022-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  10. 2022-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2022-04-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2022-04-26
    Health check-in — day 7, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  13. 2022-05-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-05-10
    Survey response — day 21, dose 2
    MedDRA: Medical counselling, Muscle spasms, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Symptoms: Severe joint and muscle spasms · Healthcare visit (other): Hime House Nurse came
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-05-10
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  16. 2022-05-11
  17. 2022-05-13
  18. 2022-05-17
    Survey response — day 28, dose 2
    MedDRA: Muscle spasms — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Muscle cramps
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-05-17
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  20. 2022-05-18
  21. 2022-05-18
  22. 2022-05-24
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  23. 2022-05-31
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Muscle spasms — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe fatigue and muscle cramps
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-05-31
    Report sent to call center — day 42, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  25. 2022-06-01
    Call successful
    Participant prefers to complete VAERS report online
  26. 2022-06-01
    Call successful
    Participant prefers to complete VAERS report online
  27. 2022-06-01
    Call successful
    Participant prefers to complete VAERS report online
  28. 2022-07-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-09-16
    Dose 3 — Pfizer-BioNTech
  30. 2022-09-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  31. 2022-09-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  32. 2022-09-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  33. 2022-09-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Itching · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  34. 2022-09-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  35. 2022-09-23
    Health check-in — day 7, dose 3
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  36. 2022-09-30
    Survey response — day 14, dose 3
    MedDRA: Arthralgia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: All Major joints knees elbows shoulders hips severe aches pain
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-10-07
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-10-16
    Survey response — day 28, dose 3
    MedDRA: Arthralgia, Feeling of body temperature change, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Severe joint pain and inconsistent hot and cold feelings · Healthcare visit (other): In person appointment is scheduled
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-10-16
    Report sent to call center — day 28, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  40. 2022-10-17
    Call successful
    Participant prefers to complete VAERS report online
  41. 2022-10-22
    Survey response — day 35, dose 3
    MedDRA: Chest pain, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Severe chest pains · Healthcare visit (other): Drs appointment is scheduled
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-10-22
    Report sent to call center — day 35, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  43. 2022-10-25
    Call successful
    Participant prefers to complete VAERS report online
  44. 2022-10-28
    Survey response — day 42, dose 3
    MedDRA: Arthralgia, Chest pain, Dyspnoea, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Shortness of breath major joint pain chest pain · Healthcare visit (other): Appointment scheduled for this Monday October 31 2022
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-10-28
    Report sent to call center — day 42, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  46. 2022-10-31
  47. 2022-12-16
    Survey response — 3 months, dose 3
    MedDRA: Angina pectoris, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Hospitalization
    Free text: Symptoms: Extreme heart/chest pain · Healthcare visit (other): Cardiologist Appointment and received a zygote home heart monitor
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-12-16
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
  49. 2022-12-19
    Call successful
    Participant prefers to complete VAERS report online
  50. 2022-12-19
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12022-03-29Pfizer-BioNTech No
22022-04-19Pfizer-BioNTech No
32022-09-16Pfizer-BioNTech No

Call center

7 call center cases

7 successful

See the call center timeline

Free text

Release 11 — day 0, dose 2

2022-04-19

Systemic reaction (other): Tiredness

Release 11 — days 1–6 daily, dose 2

2022-04-20

Systemic reaction (other): I have fibromyalgia so I believe the shot is just heightened the pain because I do NOT have flu symptoms

Release 11 — day 21, dose 2

2022-05-10

Symptoms: Severe joint and muscle spasms
Healthcare visit (other): Hime House Nurse came

Release 11 — day 28, dose 2

2022-05-17

Symptoms: Muscle cramps

Release 11 — day 42, dose 2

2022-05-31

Symptoms: Severe fatigue and muscle cramps

Release 12 — day 14, dose 3

2022-09-30

Symptoms: All Major joints knees elbows shoulders hips severe aches pain

Release 12 — day 28, dose 3

2022-10-16

Symptoms: Severe joint pain and inconsistent hot and cold feelings
Healthcare visit (other): In person appointment is scheduled

Release 12 — day 35, dose 3

2022-10-22

Symptoms: Severe chest pains
Healthcare visit (other): Drs appointment is scheduled

Release 12 — day 42, dose 3

2022-10-28

Symptoms: Shortness of breath major joint pain chest pain
Healthcare visit (other): Appointment scheduled for this Monday October 31 2022

Release 12 — 3 months, dose 3

2022-12-16

Symptoms: Extreme heart/chest pain
Healthcare visit (other): Cardiologist Appointment and received a zygote home heart monitor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling · · ✓
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAngina pectoris · · ✓
SDArthralgia · · ✓
SDChest pain · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDFeeling of body temperature change · · ✓
SDMuscle spasms · · ✓
SDUnevaluable event · · ✓
SROCondition aggravated · · ✓
SROFatigue · · ✓
SROPre-existing disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release